Title:
抗癌用薬学組成物
Document Type and Number:
Japanese Patent JP6691635
Kind Code:
B2
Abstract:
The present invention provides a pharmaceutical composition for treating or preventing cancer, containing, as an active ingredient, a compound having a specific chemical structure and an activity of inhibiting the formation of a c-Myc/Max/DNA complex, or a pharmaceutically acceptable salt thereof. The present invention provides a medical use of the pharmaceutical composition, according to the present invention, for treating or preventing cancer. The present invention also provides a method for treating or preventing cancer, comprising administering, to a subject in need of treatment, an effective amount of the compound, the salt thereof, or the composition, according to the present invention, containing both the compound and the salt thereof.
Inventors:
Chung, Kyung Choi
Im, Hwang Chung
Park, Song Chun
Seo, Hokyung
Anne, Kyung Ok
Lee, San Chin
Lee, Unsk
Im, Hwang Chung
Park, Song Chun
Seo, Hokyung
Anne, Kyung Ok
Lee, San Chin
Lee, Unsk
Application Number:
JP2019503984A
Publication Date:
April 28, 2020
Filing Date:
July 27, 2017
Export Citation:
Assignee:
National Cancer Center
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
International Classes:
A61K31/47; A61K31/4709; A61P35/00; A61P35/02; A61P43/00
Other References:
J. Biomed. Sci. Eng. 2012, Vol.5, No.1, pp.1-9
Attorney, Agent or Firm:
Patent Business Corporation Unias International Patent Office